Literature DB >> 28627267

β-Cyclodextrin-based ternary complexes of haloperidol and organic acids: the effect of organic acids on the drug solubility enhancement.

Prisada Rakkaew1, Jiraphong Suksiriworapong1,2, Doungdaw Chantasart1,2.   

Abstract

Haloperidol (HALO) is a weak base with very low aqueous solubility that is used as an antipsychotic drug. This study aimed to improve its solubility by forming HALO/β-cyclodextrin (β-CD)-based ternary complexes with organic acids. The solubility of HALO/β-CD binary and HALO/β-CD/organic acid ternary complexes in different media (i.e. citrate buffer pH 3 and 6) was explored. The stoichiometric ratio between the drug and β-CD was 1:1 in all complexes formed. The solubility of HALO/β-CD binary complexes significantly increased in citrate buffer pH 3 compared with citrate buffer pH 6. For the ternary complexes, HALO/β-CD/tartaric acid and HALO/β-CD/lactic acid in citrate buffer pH 3 increased HALO solubility compared with HALO/β-CD/succinic acid due to their higher unionized species. The highest stability constant and complexation efficiency values in citrate buffer pH 3 were shown by the ternary complexes with lactic acid followed by tartaric acid and succinic acid, respectively. Results indicated that lactic acid provided the greatest binding strength and solubilization efficiency for the complex.

Entities:  

Keywords:  haloperidol; lactic acid; solubility; succinic acid; tartaric acid; ternary complex; β-cyclodextrin

Mesh:

Substances:

Year:  2017        PMID: 28627267     DOI: 10.1080/10837450.2017.1344993

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  2 in total

1.  Aniline trimer-including carboxymethylated β-cyclodextrin as an efficient corrosion inhibitor for Q235 carbon steel in 1 M HCl solution.

Authors:  Feng Yang; Yu Liu; Tong Liu; Shuan Liu; Haichao Zhao
Journal:  RSC Adv       Date:  2019-09-25       Impact factor: 4.036

2.  Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study.

Authors:  Marianne J Naguib; Amal I A Makhlouf
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.